Zobrazeno 1 - 10
of 45
pro vyhledávání: '"James A. Bassuk"'
Autor:
James A Bassuk, Ida M Washington
Publikováno v:
PLoS ONE, Vol 9, Iss 4, p e90076 (2014)
The goal of this study was to test the hypothesis that reintroduction of Continuous Performance Improvement (CPI) methodology, a lean approach to management at Seattle Children's (Hospital, Research Institute, Foundation), would facilitate engagement
Externí odkaz:
https://doaj.org/article/591d916219a541298fde1910bc8effb2
Autor:
James A Bassuk, Ida M Washington
Publikováno v:
PLoS ONE, Vol 8, Iss 10, p e76833 (2013)
The purpose of this study was to illustrate the application of A3 Problem Solving Reports of the Toyota Production System to our research vivarium through the methodology of Continuous Performance Improvement, a lean approach to healthcare management
Externí odkaz:
https://doaj.org/article/8b226760e526437e862ffd75dc68dc1e
Autor:
James A. Bassuk
Nuclei from Drosophila melanogaster embryos contain two major nonhistone chromosomal proteins which are extracted by 0.35 NaCl and by 2% perchloric acid. A63 (M^ about 63,000) and A13 (M^ about 10,000) both contain high levels of basic and acidic ami
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::6d10326db55e5e70aa3085fe5c32e650
https://doi.org/10.31274/rtd-180813-8557
https://doi.org/10.31274/rtd-180813-8557
Autor:
Hongyong Zhang, Christopher P. Evans, Ralph W deVere White, Kit S. Lam, Chong-Xian Pan, Paul T. Henderson, Olulanu H. Aina, James A. Bassuk, Primo N. Lara, Xiaobing Wang
Publikováno v:
Urologic Oncology: Seminars and Original Investigations. 30:635-645
To develop bladder cancer-specific ligands using a combinatorial chemistry approach.We performed a high-throughput one-bead one-compound combinatorial chemistry approach to identify ligands that bound to bladder transitional cell carcinoma cells. The
Autor:
Hans Reinecke, Michael A. Portman, James A. Bassuk, Rocky Eastman, Julia Barboza, Dolena R Ledee, Xue Han Ning, Norman E. Buroker, Jie Yu Huang
Publikováno v:
The Protein Journal. 31:75-83
A peroxisome proliferator-actived receptor (PPAR) response element (RE) in the promoter region of the adaptor-related protein complex 2, alpha 2 subunit (AP2α2) of mouse heart has been identified. The steroid hormone nuclear PPARs and the retinoid X
Autor:
Bryan B. Voelzke, Hunter Wessells, Felix I. Simonovsky, James A. Bassuk, Erasmo A. Lopez, Buddy D. Ratner, Rocky Eastman, Bryson G. Hicks
Publikováno v:
Biomaterials. 32:797-807
Cell-seeded synthetic polymer scaffolds constitute an emerging technology for urethroplastic applications. The study goal was to identify urethral proteins appropriate for cell attachment and optimize their adsorption onto two types of scaffolds: por
Autor:
Tarkan Soygür, Jay S. Charleston, Eric D. Rubio, Jan Fan Cheng, Shelly Bagai, J. Chadwick Plaire, James A. Bassuk, Lynne B. Charleston, Chang Hee Han, Kimberly Cochrane, Thomas S. Lendvay, Robert M. Sweet
Publikováno v:
American Journal of Physiology-Renal Physiology. 293:F1147-F1156
Diseases and conditions affecting the lower urinary tract are a leading cause of dysfunctional sexual health, incontinence, infection, and kidney failure. The growth, differentiation, and repair of the bladder's epithelial lining are regulated, in pa
Publikováno v:
Tissue Engineering. 13:2219-2225
Synthetic urothelium is an important goal for the tissue-engineering field that would have great utility for treating diseases and congenital defects affecting the urinary tract. A key step in the development of synthetic tissue is optimizing the con
Publikováno v:
Journal of Molecular Biology. 371:883-901
SPARC (secreted protein acidic and rich in cysteine), although primarily known as a secreted, matricellular protein, has also been identified in urothelial cell nuclei. Many biological activities, including inhibition of cell adhesion and repression
Publikováno v:
American Journal of Physiology-Renal Physiology. 291:F481-F494
Control of the regenerative properties of urothelial tissue would greatly aid the clinician in the management of urinary tract disease and disorders. Fibroblast growth factor 10 (FGF-10) is a mitogen which is particularly promising as a protein thera